W. M. Girard

1.6k total citations
12 papers, 1.2k citations indexed

About

W. M. Girard is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, W. M. Girard has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in W. M. Girard's work include Mycobacterium research and diagnosis (8 papers), Tuberculosis Research and Epidemiology (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). W. M. Girard is often cited by papers focused on Mycobacterium research and diagnosis (8 papers), Tuberculosis Research and Epidemiology (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). W. M. Girard collaborates with scholars based in United States. W. M. Girard's co-authors include David E. Griffith, Barbara A. Brown, D T Murphy, R. J. Wallace, Richard J. Wallace, J McLarty, Steven Idell, Daryl S. Fair, V A Steingrube and G O Onyi and has published in prestigious journals such as American Journal of Clinical Nutrition, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

W. M. Girard

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. M. Girard United States	11	865	732	359	227	168	12	1.2k
Atsuyuki Kurashima Japan	20	1.4k 1.7×	1.2k 1.6×	529 1.5×	400 1.8×	381 2.3×	116	1.9k
Kazunari Tsuyuguchi Japan	14	1.1k 1.3×	1.1k 1.5×	338 0.9×	74 0.3×	442 2.6×	85	1.5k
Angelika Böhme Germany	23	1.2k 1.4×	1.3k 1.8×	210 0.6×	140 0.6×	25 0.1×	59	1.8k
Gloria Mattiuzzi United States	17	896 1.0×	882 1.2×	77 0.2×	187 0.8×	97 0.6×	36	1.4k
Giampaolo Bucaneve Italy	18	610 0.7×	491 0.7×	42 0.1×	126 0.6×	82 0.5×	37	1.9k
B Dupont France	12	545 0.6×	636 0.9×	101 0.3×	90 0.4×	81 0.5×	27	802
Hideo Ogata Japan	15	613 0.7×	535 0.7×	133 0.4×	112 0.5×	247 1.5×	77	884
C. Godet France	17	544 0.6×	543 0.7×	84 0.2×	210 0.9×	87 0.5×	51	837
Shinji Maeda Japan	19	961 1.1×	840 1.1×	75 0.2×	44 0.2×	509 3.0×	71	1.3k
T Gorsuch United Kingdom	6	795 0.9×	638 0.9×	358 1.0×	83 0.4×	126 0.8×	8	911

Countries citing papers authored by W. M. Girard

Since Specialization

Citations

This map shows the geographic impact of W. M. Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. M. Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. M. Girard more than expected).

Fields of papers citing papers by W. M. Girard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. M. Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. M. Girard. The network helps show where W. M. Girard may publish in the future.

Co-authorship network of co-authors of W. M. Girard

This figure shows the co-authorship network connecting the top 25 collaborators of W. M. Girard. A scholar is included among the top collaborators of W. M. Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. M. Girard. W. M. Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Vankayalapati, Ramakrishna, Benjamin Wizel, Buka Samten, et al.. (2001). Cytokine Profiles in Immunocompetent Persons Infected withMycobacterium aviumComplex. The Journal of Infectious Diseases. 183(3). 478–484. 89 indexed citations

Griffith, David E., et al.. (2001). Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease. Clinical Infectious Diseases. 32(11). 1547–1553. 78 indexed citations

Griffith, David E., et al.. (1998). Initial (6-Month) Results of Three-Times-Weekly Azithromycin in Treatment Regimens for Mycobacterium avium Complex Lung Disease in Human Immunodeficiency Virus-Negative Patients. The Journal of Infectious Diseases. 178(1). 121–126. 58 indexed citations

Griffith, David E., Barbara A. Brown, W. M. Girard, D. T. Murphy, & R. J. Wallace. (1996). Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 23(5). 983–989. 74 indexed citations

Brown, Barbara A., et al.. (1996). Clarithromycin Regimens for Pulmonary Mycobacterium Avium Complex. The First 50 Patients. American Journal of Respiratory and Critical Care Medicine. 153(6). 1766–1772. 203 indexed citations

McKinsey, D. S., Carol A. Kauffman, Peter G. Pappas, et al.. (1996). Fluconazole Therapy for Histoplasmosis. Clinical Infectious Diseases. 23(5). 996–1001. 60 indexed citations

Griffith, David E., Barbara A. Brown, W. M. Girard, & R. J. Wallace. (1995). Adverse Events Associated with High-Dose Rifabutin in Macrolide-Containing Regimens for the Treatment of Mycobacterium avium Complex Lung Disease. Clinical Infectious Diseases. 21(3). 594–598. 107 indexed citations

Holiday, D., et al.. (1995). Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. American Journal of Clinical Nutrition. 62(6). 1431S–1438S. 87 indexed citations

Wallace, Richard J., et al.. (1995). Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare Infection. The Journal of Infectious Diseases. 171(3). 747–750. 134 indexed citations

10.

Wallace, Richard J., Barbara A. Brown, David E. Griffith, et al.. (1994). Initial Clarithromycin Monotherapy for Mycobacterium Avium-Intracellulare Complex Lung Disease. American Journal of Respiratory and Critical Care Medicine. 149(5). 1335–1341. 143 indexed citations

11.

Idell, Steven, et al.. (1991). Abnormalities of Pathways of Fibrin Turnover in the Human Pleural Space. American Review of Respiratory Disease. 144(1). 187–194. 145 indexed citations

12.

Girard, W. M.. (1979). Case report: postoperative pulmonary edema and sickle cell crisis.. PubMed. 17(4). 13–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact